Operating Lease, Liability in USD of Silexion Therapeutics Corp from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Silexion Therapeutics Corp quarterly Operating Lease, Liability history and change rate from Q4 2023 to Q4 2024.
  • Silexion Therapeutics Corp Operating Lease, Liability for the quarter ending 31 Dec 2024 was $526,000.000, a 208% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Silexion Therapeutics Corp Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $526,000 +$355,000 +2.1% 31 Dec 2024 8-K 20 Aug 2025
Q4 2023 $171,000 31 Dec 2023 8-K 20 Aug 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.